03-10-2019: Exela Technologies Inc. (XELA): Who Are the Analysts that Picked This One?

(WAIT FOR PAGE TO LOAD COMPLETELY BEFORE LINKS WORK.)

Corporate Webpages
Company Profile
Company History
News
Comparison with Peers
Bond Issue
Zenith Index
Financial Statements
Avg. P/E to Current P/E
Financial Ratios
Intrinsic Value (Disc. CashFlow)
Fair Value Estimator
Projected Earnings
Research Reports
Analysts' Opinions
Insider Activity
Institutional Activity
Sentiment
Short Interest
Standard & Poor's
Management's Discussion
Channel Potential
MACD Histogram
Intraday Chart
Val Idea
Stock Consultant
Point & Figure Chart
Wall Street Analyzer
Marketspace Chart
Time Series Forecast
Neural Network Prediction
Stock Options
Ultimate Trading Systems
Recommendation

Exela Technologies Inc.

Who are the stock analysts? One definition describes them as having few minimal qualifications other than being employed as one by a major financial firm. The qualifications to begin a career as a stock analyst typically include a bachelor's degree in finance, economics, or accounting and experience working at a financial services company. To be an effective stock analyst, you need excellent mathematical reasoning, analytical, and critical thinking skills.

Based upon that, one has to be aware, among other things, if the financial firm employing the analyst does any business with the company being analyzed. Analysts have been known to tip the scales to favor clients.

Our opinion is that analyst records of success are generally worthless in picking stocks. So why do we include their opinions as a factor in rating stocks we review? The answer is that many investors pay attention to analysts and follow their recommendations, thus making predictions at times self-fulfilling prophecies. The story is much different with research organizations, which do proper analysis and do impact any sort of "value investing." Comparatively few researchers even wanted to waste time reviewing this stock, but those who did were unanimously negative on it, giving it one of the worst resarcher ratings of any stock we have reviewed.

We asked, "Who are the best analysts?" and came up with one of the so-called "top ten" in the nation on the basis of successful prediction track record. He was:

Cantor Fitzgerald’s Joseph Foresi

Top Stock Idea: Exela Technologies (XELA)

Quarterly top-line results came in above expectations for this automation company, and 2018 revenue guidance was raised. Foresi sees revenue growth acceleration pushing shares 70% to $9.

Our conclusion is that Exela Technologies (XELA) is one of the most terrible stocks we have ever reviewed. It is the "technology business", providing software to transaction processing organizations, healthcare organizations, and legal and loss prevention services, the three segments it describes as its "reporting segments." Its website, which is very poor, generalizes on many other industries for which it would like to provide services. There is no glitzy annual report, no CEO Letter to Shareholders, and in fact since 2017, no report! The company faces delisting because of late or inadequate reporting. After years of losses, it made a couple of major acquisitions bringing in business in that way to help its bottom line on a one-time basis, but apparently had trouble providng "pro forma" financial statements in a timely manner. That did not stop it from running out to sell more shares of stock to dilute shareholder value and keep the corporation afloat.

This raises another question, "What happens when you sell short a stock that is delisted?" The answer seems to be that the financial firm that lent you the stock declares it worthless and cancels your debt to buy it back. To our surprise, our broker says the stock is still "shortable."

The stock has a very poor Zenith Index, very poor fundamentals including a negative book value, a lot of intangibles in whatever value it does have, and a history of being in conflict with employees and customers.

Why would Foresi think this stock is going from $3.69 to $9.00/share? We've seen it before on a "turnaround" situation. After years of losses and missed Wall Street expectations for earnings, the company is believed to be going to report a small profit for the coming fiscal year. Of course this profit is due to the acquisitions that it made recently, which do not guarantee that under new management those organizations will continue to fare well, especially as they were up for sale in the first place.

Institutions are strong net sellers and hold less than half of the outstanding shares. Standard & Poor's is actually "neutral" on the stock, which was a surprise to us, but very negative on valuation. It considers the stock in the 'information technology' sector which in general is a moderately strong industry group. We would agree with that sector assessment, but Exela is one of the weakest performers in the group, which is highly competitive.

There are some "positives" that helped bring our Decision Matrix rating to be considerably better that that for stocks we consider much more stable and valuable. These include reasonably modest management compensation and only buying as insider trading activity even though it is quite ancient, and a quite readable well-written latest management report which we rated as positive, although the late reporting this company has exhibited should have probably turned that ratintg to a negative which would have sent the Decision Matrix score down to -5.

Based upon previous share performance of questionable companies in a similar situation, some care is urged to those going short in that they could be caught in a severe squeeze if Mr. Foresi's $9/share prediction actually happens, and we've seen things like that with other manipulated stocks of questionable value.

There is just too little reliable historical data on this company, due to its own failings, to make any reliable assessments in our opinion, and we think we were led down the garden path by Mr. Foresi on this one, and will be unlikely to use analysts in future to pick stocks to review. Certainly those reasons could well cause the stock to be "overlooked" by some of the most successful traders.

Anyway, time will tell.



[Home]
Corporate Wepages

Trade Mark
01

2

3

4
5
6
7
8
9
10
11
12
13
14
15
16



[Home]
Company Profile

Profile



[Home]
Company History
6 7 8 9 10 10


[Home]
News

Click Here for News Archives



[Home]
Comparison

Comparison

Groups 1
Groups 2
Groups 3


Companies 1
Companies 2

Similar Companies Performance:

55 56
57 58
59 60


[Home]
Bond Issue

22



[Home]
Zenith Index

Under current market conditions, a Zenith Index Score of 1.20 or above is required for a positive rating on this factor. 1.21 -1.30 is considered acceptable, 1.30-1.40 is considered strong and
> 1.40 is considered exceptionally strong. Accounting statements in this section often contain mistakes, especially in earlier years' totals, but data is deemed sufficient for us to give a rating. More accurate financial statements follow in the next section.

Exela Technologies, Inc. (XELA)                           Exchange: Nasdaq
2701 East Grauwyler Road
Irving, TX 75061                 Sector: Technology
United States                    Industry: Software

Exela Technologies, Inc. operates as a location-agnostic business
process automation (BPA) company that combines industry-specific and
multi-industry enterprise software and solutions worldwide. Its BPA
suite of solutions are deployed in banking, healthcare, insurance, and
other industries. The company's Information and Transaction Processing
Solutions segment provides lending solutions for mortgages and auto
loans; banking solutions for clearing, anti-money laundering, sanctions,
and cross-border settlement; property and casualty insurance solutions
for enrollments, claims processing, and communications; and public
sector solutions for income tax processing, benefits administration, and
records management. This segment also offers industry-agnostic
solutions; and software, hardware, and maintenance related to
information and transaction processing automation. Its Healthcare
Solutions segment provides revenue cycle solutions, integrated accounts
payable and accounts receivable, and information management for both the
healthcare payer and provider markets. The company's Legal & Loss
Prevention Services segment processes legal claims for class action and
mass action settlement administrations, involving project management
support, notification, and outreach to claimants; and collects,
analyzes, and distributes settlement funds. This segment also offers
data and analytical services in the area of litigation consulting,
economic and statistical analysis, expert witness services, and revenue
recovery services for delinquent accounts receivable. The company serves
approximately 3,700 customers, including the Fortune(R) 100 and other
retail chains, banks, law firms, healthcare insurance payers and
providers, and telecom companies. The company is headquartered in
Irving, Texas.

Last Trade:   3.78                           52-Week Range:   7.34 -   3.39
Employees: 20,700                            Avg.Volume:      84,419 Shares

Corporate Governance:
Pillar scores are Audit: 5; Board: 9; Shareholder Rights: 6; Compensation: 6.
         (A lower number means less governance risk.)

EPS: -0.74    Dividend Amount: $ 0.00          Yield:  0.00%
             Ex-Dividend Date: N/A             Payout Ratio:   0.00

Key Statistics:

    Trailing P/E:   0.00              Forward P/E (est.):  35.18
                                           Target Price:   7.38

Qrtly Stock Price Growth (yoy): -28.95%               Beta:   0.00
Qrtly S&P Index   Growth (yoy):  13.20%        Short Ratio:  17.05%
    Qrtly Revenue Growth (yoy):   0.36%         Shares Out:  151650000
   Qrtly Earnings Growth (yoy):   0.00%

          Book Value:  -0.62                    Debt/Equity:   0.00%
    Price/Book Value:   0.00        Operating Profit Margin:   3.32%
         Price/Sales:   0.37                  Profit Margin:  -8.69%
         Market Cap:     586,882,000       Return on Equity:   0.00%
    Enterprise Value:   1,890,000,000      Return on Assets:   1.90%

    Operating Cash Flow:     51,890,000
         Free Cash Flow:     85,570,000



Annual Income Statement:                          (All numbers in thousands)
  Period Ending                             12/31/2017  12/31/2016  12/31/2015

  Total Revenue                              1,152,324     789,926     805,232
  Cost of Revenue                              829,143     519,121     559,846
  Gross Profit                                 323,181     270,805     245,386

Operating Expenses:
  Research & Development                             0           0           0
  Selling, General & Administrative            239,686     140,930     129,668
  Non-Recurring Expenses                             0           0           0
  Other Operating Expenses                           0           0           0
  Total Operating Expenses                   1,167,719     739,690     764,922

Operating Income or Loss                       -15,395      50,236      40,310

Income from Continuing Operations:
  Total Other Income/Expenses Net             -249,136    -110,126    -112,026
  Earnings Before Interest & Taxes             -15,395      50,236      40,310
  Interest Expense                            -127,192    -109,414    -108,779
  Income Before Taxes                         -264,531     -59,890     -71,716
  Income Tax Expense                           -60,246     -11,787     -26,812
  Minority Interest                                  0           0           0

Net Income from Continuing Op.s               -204,285     -48,103     -44,904

Non-recurring Events:
  Discontinued Operations                            0           0           0
  Extraordinary Items                                0           0           0
  Effect of Accounting Changes                       0           0           0
  Other Items                                        0           0           0
  Net Income                                  -204,285     -48,103     -44,904
  Preferred Stock & Other Adjustments                0           0           0

Net Income Avail to Common Shares             -223,149     -48,103     -44,904



Annual Cash Flow Statement:                   (All numbers in thousands)
  Period Ending                         12/31/2017    12/31/2016    12/31/2015

  Net Income                              -204,285       -48,103       -44,904

Operating Activities:
  Depreciation                              98,890        79,639        75,408
  Adjustments to Net Income                 79,828        -5,449       -17,168
  Changes in Accounts Recv'bls              -4,832        20,801        11,583
  Changes in Liabilities                    52,953         5,544       -28,644
  Changes in Investories                         0             0             0
  Changes in other Oper'g Acts               7,535         2,542        -1,811

Total Cash Flow f Operations                42,369        68,658         7,438

Investing Activities:
  Capital Exenditures                      -14,440        -7,926       -10,669
  Investments                                    0             0             0
  Other Cash Flows fr Investing                  0             0             0

Total Cash Flows from Investing           -452,374       -31,602       -34,432

Financing Activities:
  Dividends Paid                                 0             0             0
  Sale of Purchase of Stock                      0             0             0
  Net Borrowings                           228,454       -43,255        21,618
  Other Cash Flows fr Financing            -12,955       -12,955             0

Total Cash Flows from Financing            440,215       -43,255        21,618

  Effect of Exchange Rate Chg                  429        -2,059          -672

Change in Cash & Cash Equiv.                30,639        -8,258        -6,048



Annual Balance Sheets:                              (All Numbers in Thousands)
  Period Ending                          12/31/2017    12/31/2016    12/31/2015
Current Assets:
  Cash & Cash Equivalents                    39,000         8,361        16,619
  Short Term Investments                      1,727         1,296         1,501
  Net Receivables                           229,704       138,421       145,162
  Inventory                                  11,922        11,195        13,742
  Other Current Assets                       42,489        25,892        22,403
  Total Current Assets                      328,296       183,869       197,926

  Long-Term Investments                           0             0             0
  Property, Plant & Equipt                  132,908        81,600        78,303
  Goodwill                                  747,325       373,291       359,459
  Intangible Assets                         442,054       278,498       285,229
  Accumulated Amortization                        0             0             0
  Other Assets                               44,840        40,026        27,617
  Deferred LT Asset Charges                   9,019         9,654         4,602

Total Assets                              1,714,838       969,486       960,048

Current Liabilities:
  Accounts Payable                           81,263        42,212        26,778
  Current Portion LT Debt                    20,565        55,833        45,253
  Other Current Liabilities                 112,109        70,575        45,523
  Total Current Liabilities                 373,760       237,475        191,278

  Long Term Debt                          1,276,094       983,502       975,142
  Other Liabilities                          49,032        69,971        70,511
  Deferred LT Liab. Charges                  22,930        20,241             0
  Minority Interest                               0             0             0
  Negative Goodwill                               0             0             0

Total Liabilities                         1,724,844     1,309,387     1,251,537

Stockholder Equity:
  Misc. Options, Warrants                         0             0             0
  Redeemable Preferred Stock                      0             0             0
  Preferred Stock                                 0             0             0
  Common Stock                                   15             6             0
  Retained Earnings                        -514,628      -293,968      -245,865
  Treasury Stock                             22,588       -45,939       -45,624
  Capital Surplus                           482,018             0             0
  Other Stockhohlder Equity                  22,837       -45,939       -45,624
  Total Stockholder Equity                  -10,007      -339,901      -291,489

Net Tangible Assets                      -1,199,386      -991,690      -936,177


Exela Technologies, Inc. (XELA)             [Indices near +3.0, near zero,
                                            or < zero bear special attention.]
P/E Ratio Tests:
P/E Ratio < 28?            0.0000          P/E Ratio > 5?             0.0000
P/E Ratio Vs Growth Rate:  0.0000          Forward P/E Ratio < 28?    0.7959
Price/Sales Ratio < 2.3?   3.0000          Inventory/Sales < 5%?      3.0000
Sales < $1 Billion?        0.8678          Operating Margin < 7.5%?   2.2590

Balance Sheet Tests:
Debt/Equity < 0.40?        1.0000          Long-Term Debt Service:   -0.0078
LTD Being Reduced?        -3.0000          Short-Term Debt Service:   0.1210
Current Ratio > 2?         0.4392          Working Capital >= 1.5?    1.7305
Leverage Ratio < 20%?      0.0515          Debt/Assets < 1?           1.3438
Quick Ratio > 1?           3.0000          Inventory Turnover > 1?    0.0102
Share Equity Increase:     1.1955          Market Cap.< 1.5 Billion?  2.5559
                                           Intangibles < 3% Assets?   0.0433
Income Tests:
Profit Margin < 7.5%?     -1.1586          EPS Annual Growth > 10%?   0.0216
Dividend Yield > 2.0%?     0.0000          EPS 3-yr Growth > 15?      0.0302
Enterprise Value/Revenue   0.5104          EPS Growth Consistent?    -2.0000
Enterprise Value/EBITDA:  -3.0000          Collection < 45 days?      0.6185
EPS Qrtly Growth > 10%?    0.0000          Gross Pft/Cur. LTD > 1?    3.0000
                                           Borrowing Int. Rate < 6%? -0.6020
Stock Performance Tests:
Volatility > 25%?          2.1526          % Held by Insiders < 5%?   0.0961
Beta > 1.25?               0.0000          % Held by Institut. < 50?  1.1131
50 Da MA > 200 Da MA?     -0.8517          % Held by Institut. > 30?  1.4973
52-Wk Change vs. S&P 500: -3.0000          Short Ratio > 5?           3.0000
Price/Book Value < 3?     -0.4921          Short % of Float > 20?     0.1560
Return on Assets > 17%?    0.1118          Average Volume > 100,000?  0.8442

Cash Flow Tests:
Oper. C.F. > Lever'd C.F:  0.6064          Positive Free Cash Flow?   3.0000
Positive Oper. Cash Flow?  3.0000          Price to C.F.Ratio < 14?:  3.0000
                                           Cash Flow / Assets > 10%?  3.0000

XELA   Exela Technologies, Inc.            Overall Zenith Index:      0.6749


[Home]
Financial Statements

EXELA TECHNOLOGIES INC  (XELA)              INCOME STATEMENT

Fiscal year ends in December. USD in thousan         2013-12         2014-12         2015-12         2016-12         2017-12             TTM           

Revenue                                                    0               0               0               0       1,152,324       1,572,868
Cost of revenue                                            0               0               0               0         829,143       1,193,583
Gross profit                                               0               0               0               0         323,181         379,285


Operating expenses
Sales, General and administrative                          0               0           1,028           1,128         254,386         190,525
Other operating expenses                                   0               0               0               0          98,890         137,539
Total operating expenses                                   0               0           1,028           1,128         353,276         328,064

Operating income                                           0               0          -1,028          -1,128         -30,095          51,221
Other income (expense)                                     0               0             656           1,185        -234,436        -210,400
Income before taxes                                        0               0            -372              57        -264,531        -159,179
Provision for income taxes                                 0               0               0               0         -60,246         -22,411
Net income from continuing operations                      0               0            -372              57        -204,285        -136,768
Net income                                                 0               0            -372              57        -204,285        -136,768
Preferred dividend                                         0               0               0               0          18,864           4,006
Net income available to common shareholders                0               0            -372              57        -223,149        -140,774

Earnings per share
Basic                                                   0.00            0.00           -0.04            0.01           -2.08            1.37 
Diluted                                                 0.00            0.00           -0.04            0.01           -2.08            1.37 

Weighted average shares outstanding
Basic                                                      0               0          10,261          10,414         107,068         190,312
Diluted                                                    0               0          10,261          10,414         107,068         190,312

____________________________________________________________________________________________________________________________________________


EXELA TECHNOLOGIES INC  (XELA)              BALANCE SHEET

Fiscal year ends in December. USD in thousan         2013-12         2014-12         2015-12         2016-12         2017-12             

Assets

Current assets

Cash

Total cash                                                 0               1             882             120          39,000

Receivables                                                0               0               0               0         199,201
Inventories                                                0               0               0               0          11,922
Prepaid expenses                                           0              27              75               0          22,869
Other current assets                                       0               0               0               0          74,719
Total current assets                                       0              28             957             120         347,711

Non-current assets

Property, plant and equipment
Gross property, plant and equipment                        0               0               0               0         264,562
Accumulated Depreciation                                   0               0               0               0        -131,654
Net property, plant and equipment                          0               0               0               0         132,908

Goodwill                                                   0               0               0               0         747,325
Intangible assets                                          0               0               0               0         464,984
Deferred income taxes                                      0               0               0               0           9,019
Other long-term assets                                     0             184         350,155         351,088          12,891
Total non-current assets                                   0             184         350,155         351,088       1,367,127

Total assets                                               0             212         351,112         351,209       1,714,838 

Liabilities and stockholders' equity

Liabilities

Current liabilities
Short-term debt                                            0             241               0               0          20,565
Capital leases                                             0               0               0               0          15,611
Accounts payable                                           0               0               0               0          81,263
Taxes payable                                              0               0               0               0          12,922
Accrued liabilities                                        0               0               0               0          93,971
Deferred revenues                                          0               0               0               0          44,365
Other current liabilities                                  0               0              67             107         105,063
Total current liabilities                                  0             241              67             107         373,760

Non-current liabilities
Long-term debt                                             0               0               0               0       1,276,094
Capital leases                                             0               0               0               0          25,958
Deferred taxes liabilities                                 0               0               0               0           5,362
Accrued liabilities                                        0               0               0               0           1,144
Deferred revenues                                          0               0               0               0             424
Pensions and other benefits                                0               0               0               0          28,272
Other long-term liabilities                                0               0         346,044         346,101          13,830
Total non-current liabilities                              0               0         346,044         346,101       1,351,084

Total liabilities                                          0             241         346,112         346,209       1,724,844 

Stockholders' equity

Preferred stock                                            0               0               0               0               1
Common stock                                               0               1               1               1              15
Additional paid-in capital                                 0              24           5,424           5,367         482,018
Retained earnings                                          0             -53            -425            -368        -514,628
Treasury stock                                             0               0               0               0            -249
Accumulated other comprehensive income                     0               0               0               0          22,837
Total stockholders' equity                                 0             -28           5,000           5,000         -10,006
Total liabilities and stockholders' equity                 0             212         351,112         351,209       1,714,838

____________________________________________________________________________________________________________________________________________


EXELA TECHNOLOGIES INC  (XELA)              Statement of CASH FLOW

Fiscal year ends in December. USD in thousan         2013-12         2014-12         2015-12         2016-12         2017-12             TTM           

Cash Flows From Operating Activities
Net income                                                 0               0            -372              57        -204,285        -136,768
Depreciation & amortization                                0               0               0               0          98,890         137,539
Amortization of debt discount/premium and is               0               0               0               0          12,280          10,658
Investment/asset impairment charges                        0               0               0               0          69,437               0
Deferred income taxes                                      0               0               0               0         -66,723         -33,226
Stock based compensation                                   0               0               0               0           6,743           6,813
Change in working capital                                  0               0              20             115          55,656         -34,720
Accounts receivable                                        0               0               0               0          -4,832          -8,422
Prepaid expenses                                           0               0             -48              75           2,628          -3,331
Other working capital                                      0               0              67              40          57,860         -22,967
Other non-cash items                                       0               0            -155          -1,185          70,371         101,594
Net cash provided by operating activities                  0               0            -507          -1,014          42,369          51,890

Cash Flows From Investing Activities
Investments in property, plant, and equipmen               0               0               0               0         -14,440         -21,516
Property, plant, and equipment reductions                  0               0               0               0              25               0
Acquisitions, net                                          0               0               0               0        -419,124          -6,882
Purchases of intangibles                                   0               0               0               0          -7,843          -4,575
Other investing activities                                 0               0        -350,000             252         -10,992          -6,736
Net cash used for investing activities                     0               0        -350,000             252        -452,374         -39,709

Cash Flows From Financing Activities
Debt issued                                                0               0               0               0       1,396,216          63,144
Debt repayment                                             0               0               0               0      -1,167,552         -58,106
Common stock issued                                        0               0         351,629               0         204,417         -27,031
Common stock repurchased                                   0               0               0               0            -249          -5,148
Other financing activities                                 0               0            -241               0           7,383         -16,218
Net cash provided by (used for) financing                  0               0         351,388               0         440,215         -43,359

Effect of exchange rate changes                            0               0               0               0             429            -460
Net change in cash                                         0               0             881            -762          30,639         -31,638
Cash at beginning of period                                0               0               1             882           8,361          64,689
Cash at end of period                                      0               0             882             120          39,000          33,051

Free Cash Flow
Operating cash flow                                        0               0            -507          -1,014          42,369          51,890
Capital expenditure                                        0               0               0               0         -22,283         -26,091
Free cash flow                                             0               0            -507          -1,014          20,086          25,799
____________________________________________________________________________________________________________________________________________





[Home]
Average to Current P/E Ratios
              (XELA)     Exela Technologies Inc.

                               2015    2016    2017    2018    2019

          Annual Earnings:     0.00    0.00   -0.04   -2.08    1.37
Average Price During Year:     9.80   10.00    7.00    5.70    5.00

                P/E Ratio:    98.00  100.00  175.00    2.74    3.65

 Average 5-Year P/E Ratio  =  75.88
             Current Price =  3.72

          Current Annualized (Last Four Quarters) Earnings =   1.87
                                                           ________
                                 Average PE / Current PE =    38.14
                                                           --------

                                      ...a number above 1.00 is good
                                                1.00 or below is bad


[Home]
Financial Ratios

. . . . . . . . . . . . Lowest to Highest, Compared to Industry



[Home]
Intrinsic Value (DCF)

Intrinsic Value by Discounted Cash Flow Method:

Intrinsic Value



[Home]
Fair Value Estimator

Fair Value Estimate:

Fair ValueFair Value



[Home]
Projected Earnings

Earnings Estimates



[Home]
Research Reports

Click Here for Research Reports



[Home]
Analysts' Opinions

Analysts' Opinion 1
Analysts' Opinion 1
Analysts' Opinion 1
Analysts' Opinion 1
Analysts' Opinion 2



[Home]
Insider Activity

Insiders Chart Insider Trades
Insider Trades
Executive Compensation Executive Compensation



[Home]
Institutional Activity

Institutional Orders to Buy or Sell:

institutions 1
Ownership:

institutions 2


[Home]
Sentiment

sentiment

Zenith uses the "sentiment" score above or below 50 to award a positive or negative point in the Decision Matrix.

sentiment sentiment sentiment



[Home]
Short Interest Ratio

As the short interest rises as a percentage of average daily share volume (Days to Cover), this is considered a measure of negative sentiment. Similarly, a decrease in that percentage is considered positive sentiment.

short interest short interest


[Home]
Standard & Poor's

S&P Stock Report (Requires Adobe Acrobat Reader)



[Home]
Management's Discussion of Results of Operations Excerpts

Click Here for Management's Discussion Excerpts



[Home]
Channeling Potential

 
The summary below includes a value for `Degree,' which refers on a
scale of 1 to 10 the range of a channel in the period under consi-
deration compared to the total range of price movement. It also looks
for the last closing price to be within the channel, otherwise zeroed.
The `Index' is the `Degree' weighted for volatility.  Generally, the
the higher the index, the more suitable is the stock for trading as
a `rolling stock' between channel high and low points.

Results for EXELA TECHNOLOGIES INC.:
Symbol? XELA
Total Months Available:  32
       Months in Cycle?   4

Months Covered by Periods:  12

Period 1           Period 2          Period 3
   H1      L1        H2      L2        H3      L3
   5.95    4.15      7.34    4.48      6.54    3.39

RANGE   =   7.34  TO    3.39            Close =   3.74
CHANNEL =   5.95  TO    4.48           Degree =   4
Volatility =  39.30%                    Index =  15
Channel Chart



[Home]
MACD Histogram Divergence

The theory is that connecting the two most recent peaks or valleys of the MACD histogram will signal the direction of the next major move.



[Home]
Intraday Chart

2 Days:



[Home]
Val Idea

2 out of 8 favorable, (negativel opinion.)

Val Idea
Val Idea


[Home]
Stock Consultant

Stock Consultant Stock Consultant


[Home]
Point & Figure Chart

P & F Chart


[Home]
Wall Street Analyzer



[Home]
Marketspace Chart

Marketspace Chart



[Home]
Time Series Forecast

Time Series 1 Time Series 2


[Home]
Neural Network Prediction

"Neurostock" can only track long trades. Therefore its performance, as tracked by itself on stocks which are consistently falling, may not appear as good as it could if each "sell" signal were a "short sale."

Neural Chart
Heading
Neural Trades Neural Prediction



[Home]
Ultimate Trading Systems

2 out of 3 of the ultimate systems favor a downmove.


System Below:
Short term outlook: Positive: Bright Green, Negative: Bright Red
Long term outlook: Postive: Dark Green, Negative: Dark Red.




[Home]
Recommendation

Decision Weighting Factors
FactorsWeighted Points
News - 1
Comparison + 1
Industry + 1
Bond Issue 0
Zenith Index - 1
Non-GAAP vs. GAAP Earnings + 1
Cash Flow - 1
Average to Current P/E + 1
Ratios - 1
Intrinsic Value DCF 0
Fair Value Estimator + 1
Projected Earnings + 1
Research Reports - 1
Analysts + 1
Executive Perquisites + 1
Insider Activity + 1
Institutional Activity - 1
Management Reporting + 1
Short Interest + 1
Sentiment - 1
Standard & Poor's - 1
MACD Histogram Divergence - 1
Val Idea - 1
Stock Consultant + 1
Point & Figure - 1
Wall Street Analyzer + 1
Marketspace Chart - 1
Time Series Chart - 1
Neural Network - 1
Stock Options - 1
Ultimate Trading Systems - 1
Total - 3
Place 9,999 shares of Exela Technologies, Inc. ( XELA ) on the Active List.